You are here

Antenatal Kontrollerde PAP Smear Taraması ve Sonuçları

RESULTS OF PAP SMEAR SCREENING IN ANTENATAL EXAMINATIONS

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Aim: We aimed to evaluate the PAP smears of 194 pregnant women who applied to the antenatal outpatient clinic of Haydarpaşa Numune Training and Research Hospital and screen the infectious and neoplastic lesions of the cervix. Materials and Methods: PAP smears were taken using Ayre spatulas from 194 randomly chosen pregnant women who stated that they hadn't had a PAP smear for the past year. The PAP smears were evaluated in the pathology laboratory using the Bethesda system. Results: 37.11% of the pregnant women had normal results whereas 55.15% had signs of infections and inflammation, 5.67% reactive and reparative changes, 1.55% ASCUS, and 0.51% HGSIL. Conclusion: Antenatal controls are a good opportunity for performing PAP smears in countries where periodic health controls are not routinely performed, like Turkey. We believe that, PAP smears must be an integral part of the routine examination.
Abstract (Original Language): 
Amaç: Bu çalışmada gebe polikliniğine antenatal kontrol için başvuran 194 gebeden PAP smear alınarak serviksin neoplas-tik ve enfeksiyöz değişikliklerinin değerlendirilmesi amaçlandı. Gereç ve Yöntem: Rastgele seçilen ve son bir yıldır smear al¬dırmadığını bildiren 194 gebeden Ayre spatulası kullanılarak PAP smear alındı, patoloji laboratuvarında incelenerek Bethes-da sistemi ile değerlendirildi. Bulgular: Gebelerin smear sonuçlarının %37.11'i normal sınırlarda bulunurken %55.15'inde enfeksiyon bulguları, %5.67'sinde reaktif ve reparatif değişiklikler, %1.55'inde ASCIIS, %0.51'inde HGSIL tespit edildi. Sonuç: Ülkemizde olduğu gibi periyodik sağlık kontrollerine gitme alışkanlığı olmayan toplumlarda gebelik kontrolleri için doktora başvurulması, PAP smear taraması için iyi bir fırsattır. Rutin muayenenin bir bölümü haline getirilmesi PAP smear uygulanmasının yaygınlaşmasını sağlayacaktır.
111-115

REFERENCES

References: 

1. Cramer DW. The role of cervical cytology in the declining morbidity and mortality of cervical cancer. Cancer 1974; 34: 2018-27.
2. Sigurdsson K. Effect of organized screening on the risk of cervical cancer: Evaluation of screening activity in Iceland, 1964-1991. Int J Cancer 1993: 54; 563-70.
3. La Vecchia C, Franceschi S, Decarli A,Fasoli M, Gentile A, Tognoni
G. PAP Smear and the risk of cervical neoplasia: quantitative estimates from a case control study. Lancet 1984; 2: 779-82.
4. Herrero R, Brinton LA, Reeves WC ve ark. Screening for cervical cancer in Latin America: a case-control study. Int J Epidemiol 1992; 21:
1050-56.
5.
Aydınl
ı K, Bozkurt S, Ergün E. Kadınlarda genital kanser insidansı. Jinekoloji ve Obstetrik Dergisi 1987; 1: 33-8.
6.
Arva
s M, Kaleli S. Gebelik ve Kanser. Jinekolojik Onkoloji'de Ed. Ata-sü T, Aydınlı K. İstanbul, Logos, 1996: 488.
7. Boutselis JG. Intraepithelial carcinoma of the cervix associated with pregnancy. Obstet Gynecol 1972; 40: 657-66.
8. Morimura Y, Fujimori K, Soeda S ve ark. Cervical cytology during pregnancy-comparison with non-pregnant women and management of pregnant women with abnormal cytology. Fukushima J Med Sci 2002; 48(1): 27-37.
9. Paraiso MF. Evaluation of the endocervical Cytobrush and Cervex-brush in pregnant women. Obstet Gynecol 1994; 84: 539-43.
10. Jimenez Cordero AA, de Alba EGE. Colpocytology in pregnancy. Gynecol Obstet Mexico 1995; 63: 33-7.
11. Pairwuti S. PAP smear examinations in women with near-term preg¬nancy. J Med Assoc Thai 1991; 74: 156-8.
12. Pisharodi L, Jovanoska S. Spectrum of cytologic changes in preg-nanccy. Acta Cytol 1995; 39: 905-8.
13. Schneider A, Hotz M, Gissmann L. Increased prevalance of human pa-pilloma viruses in the lower genital tract of pregnant women. Int J Can¬cer 1987; 40: 198-201.
14. Smith EM, Johnson SR, Jiang D ve ark. The association between preg¬nancy and human papilloma virus prevalence. Cancer Detection and Prevention 1991;15(5):397-402 15. Chang-Cleude J, Schneider A, Smith E ve ark. Longitudinal study of the effects of pregnancy and other factors on detection of HPV. Gynecol Oncol 1996; 60: 355-62.
16. Hacker NF, Berek JS, Lagasse LD, Charles EH, Savage EW, Moore
JG. Carcinoma of the cervix associated with pregnancy. Obstet Gynecol
1982; 59: 735-46.
17. Chhieng DC,Elgert P, Cangiarella JF, Cohen JM. Significance of
AGUS PAP Smears in pregnant and postpartum women. Acta Cytol 2001;
45: 294-9.
18. American Cancer Society. Cancer Facts and Figures 1993. Atlanta, American Cancer Society, 1993.
19. Dindelli M, Parazzini F, Rabaiotti E, Ferrari-A. Assessment of the use of PAP test in a sample of pregnant women. Minerva Gynecol 1990; 42:
305-8.
20. Thomas DB, Ray RM, Pardthaisong T ve ark. Prostituition, condom use, and invasive squamous cell cervical cancer in Thailand. Am J Epidemiol 1996; 143: 779-86.
21. Armstrong BK, Munoz N, Bocsh FX. Epidemiology of Cancer of the Cervix. Gynecologic Oncology'de Ed. Coppleson M, Monaghan JM, Morrow CP, Tattersall MHN. New York, Churchill Livingstone, 1992;
11-29.
22. Siddiqui G, Kurzel RB, Lampley EC, Kang HS, Blankstein J. Cer¬vical dysplasia in pregnancy: Propression versus regression post-partum. Int J Fertil Womens Med 2001; 46: 278-80.
23. Strinic T, Bukovic D, Karelovic D, Bojic L, Stipic I. The effect of delivery on regression of abnormal cervical cytologic findings. Coll Ant-
ropol 2002; 26: 577-82.
24. Vlahos G, Rodolakis A, Diakomanolis E ve ark. Conservative manage¬ment of cervical intraepithelial neoplasia (CIN 3) in pregnant women.
Gynecol Obstet Invest 2002; 54: 78-81.
25. Smith EB, Creasman WT. Preinvasive and invasive cervical neoplasia.
Cancer 1988; 186:1132-7.
|
Tuzcular Vural EZ ve ark. | Antenatal Kontrollerde PAP Smear Taraması ve Sonuçları
26. Levitt C, Shaw E, Wong S ve ark. systematic review of the literature on postpartum care: selected contraception methods, postpartum papanico-laou test, and rubella immunization. Birth 2004; 31: 203-12.
27. Nahhas WA, Clark MA, Brown M. 'Abnormal' Papanicolaou smears and colposcopy in pregnancy: ante-and post-partum findings. Int J
Gynecol Cancer 1993; 3: 239-44.

Thank you for copying data from http://www.arastirmax.com